WHO ICTRP trial
Comparison of the effects of medroxyprogestron and megestrol on vasomotor…
IRCT20210412050945N1 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20210412050945N1 |
|---|---|
| Public title | Comparison of the effects of medroxyprogestron and megestrol on vasomotor symptom in menopause women |
| Scientific title | Comparison of the effects of medroxyprogestron 10 mg and megestrol 40 mg on vasomotor symptom in menopause women |
| Primary sponsor | Karaj University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Menopausal hot flashes. Menopausal and other perimenopausal disorders |
| Interventions | Intervention 1: Intervention group: Magestrol tablets 40 mg daily for 1 month. Intervention 2: Intervention group: Medroxyprogesterone 10 mg daily for one month. |
| Registration date | May 2, 2021 |
| Target size | 80 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: